Skip to content

Ayurvedic management of allergic rhinitis with Karpasasthyadi Taila Nasya and Gudardraka Avaleha, which is indicated in Nasal desorders.

Efficacy of Gudardraka Avaleha with and without Karpasasthyadi Taila Nasya in the management of Vataja Pratishyaya (Allergic rhinitis) - An open labelled randomized comparative clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055669
Enrollment
100
Registered
2023-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda, Jamnagar
Lead Sponsor
Harikrishnan N Menon
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subjects showing the signs and symptoms of Vataja Pratishyaya (Allergic Rhinitis) i.e., Kshavthu (Sneezing), Nasa Srava (Nasal discharge), Nasaavrodha (Nasal obstruction), Shira Shoola or Shanka vedana (Headache), Kandu (Itching in eye, palate, pharynx), Mukha-Talu-Oshta-Gala Shosha (Dryness), Svarophaghata (Hoarseness of voice). 2) Patient will be selected irrespective of Gender, Occupation, Religion, Socio-Economic status.

Exclusion criteria

Exclusion criteria: 1) Patient below the age group of 18 and above 50 years. 2) Cases which require surgical intervention like nasal polyps would be excluded. 3) Patients suffering from any chronic debilitating disease like Tuberculosis, Diabetes Mellitus, Asthma and other respiratory or nasal problems. 4) Pregnant ladies and lactating mothers.

Design outcomes

Primary

MeasureTime frame
Change in Total nasal symptom score (TNA) for sneezing, Nasal discharge, Nasal obstruction, Itching of nose-palate-throat in allergic rhinitisTimepoint: on 0 (Before Treatment), 8th day, 18th day, 30th day (after treatment)

Secondary

MeasureTime frame
Change in routine blood investigation like AEC, ESR. Change in Diamine Oxidase (DAO) enzyme. Change in the Quality of life will be assessed using MRQLQ questionnaire Timepoint: on 0 (Before Treatment) & 30th day (after treatment)

Countries

India

Contacts

Public ContactHarikrishnan N Menon

Institute of Teaching and Research in Ayurveda, Jamnagar

drrajshreeunadkat@yahoo.com9427242598

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026